Mount Sinai Hospital, University of Toronto, 600 University Street, Suite 476, Toronto, Ontario M5G 1X5, Canada.
Bone Joint J. 2013 Jun;95-B(6):777-81. doi: 10.1302/0301-620X.95B6.31346.
In this retrospective study we evaluated the proficiency of shelf autograft in the restoration of bone stock as part of primary total hip replacement (THR) for hip dysplasia, and in the results of revision arthroplasty after failure of the primary arthroplasty. Of 146 dysplastic hips treated by THR and a shelf graft, 43 were revised at an average of 156 months, 34 of which were suitable for this study (seven hips were excluded because of insufficient bone-stock data and two hips were excluded because allograft was used in the primary THR). The acetabular bone stock of the hips was assessed during revision surgery. The mean implant-bone contact was 58% (50% to 70%) at primary THR and 78% (40% to 100%) at the time of the revision, which was a significant improvement (p < 0.001). At primary THR all hips had had a segmental acetabular defect > 30%, whereas only five (15%) had significant segmental bone defects requiring structural support at the time of revision. In 15 hips (44%) no bone graft or metal augments were used during revision. A total of 30 hips were eligible for the survival study. At a mean follow-up of 103 months (27 to 228), two aseptic and two septic failures had occurred. Kaplan-Meier survival analysis of the revision procedures demonstrated a ten-year survival rate of 93.3% (95% confidence interval (CI) 78 to 107) with clinical or radiological failure as the endpoint. The mean Oxford hip score was 38.7 (26 to 46) for non-revised cases at final follow-up. Our results indicate that the use of shelf autografts during THR for dysplastic hips restores bone stock, contributing to the favourable survival of the revision arthroplasty should the primary procedure fail.
在这项回顾性研究中,我们评估了货架自体移植物在修复髋关节发育不良初次全髋关节置换术(THR)中骨量的效果,以及初次置换失败后翻修关节置换术的结果。在 146 例接受 THR 和货架移植物治疗的发育不良髋关节中,有 43 例在平均 156 个月时进行了翻修,其中 34 例适合本研究(7 例因骨量数据不足而被排除,2 例因初次 THR 中使用同种异体移植物而被排除)。在翻修手术中评估了髋关节的髋臼骨量。初次 THR 时的平均植入物-骨接触率为 58%(50%至 70%),翻修时为 78%(40%至 100%),这是显著的改善(p<0.001)。初次 THR 时,所有髋关节均存在>30%的节段性髋臼缺损,而在翻修时仅有 5 髋(15%)存在需要结构性支撑的显著节段性骨缺损。在 15 髋(44%)中,翻修时未使用骨移植物或金属增强物。共有 30 髋符合生存研究条件。平均随访 103 个月(27 至 228)后,发生了 2 例无菌性和 2 例感染性失败。翻修手术的 Kaplan-Meier 生存分析显示,以临床或影像学失败为终点,十年生存率为 93.3%(95%置信区间 78 至 107)。最终随访时非翻修病例的牛津髋关节评分平均为 38.7(26 至 46)。我们的结果表明,在髋关节发育不良初次 THR 中使用货架自体移植物可恢复骨量,如果初次手术失败,有助于翻修关节置换术的良好生存。